XML 92 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Leases
12 Months Ended
Dec. 31, 2019
Leases [Abstract]  
Leases

Note 7 – Leases

The components of lease expense were as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Operating lease cost

 

$

15,005

 

Short-term lease cost

 

 

498

 

Variable lease cost

 

 

5,318

 

Sublease income

 

 

(205

)

Total lease cost

 

$

20,616

 

 

Additional lease information is summarized in the following table (in thousands, except lease term and discount rate):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Cash paid for amounts included in the measurement of operating

   lease liabilities

 

$

10,953

 

Operating right-of-use assets obtained in exchange for lease

   obligations

 

$

18,497

 

Weighted-average remaining lease term - operating leases (years)

 

 

6.4

 

Weighted-average discount rate - operating leases

 

 

5.1

%

 

Future minimum lease payments under non-cancellable leases as of December 31, 2019 are as follows (in thousands):

 

2020

$

15,904

 

2021

 

14,092

 

2022

 

13,577

 

2023

 

13,073

 

2024

 

12,673

 

Thereafter

 

23,936

 

Total lease payments

 

93,255

 

Less imputed interest

 

(13,985

)

Present value of lease liabilities

$

79,270

 

 

Lease balances are as follows (in thousands):

 

 

As of

 

 

December 31, 2019

 

Operating lease right-of-use assets

$

69,100

 

 

 

 

 

Short-term operating lease liabilities (1)

$

12,208

 

Non-current operating lease liabilities

 

67,062

 

Total operating lease liabilities

$

79,270

 

 

(1)

Included in accrued expenses and other current liabilities in the Consolidated Balance Sheets.

The Company’s leases do not contain residual value guarantees, material restrictions or covenants, and all sublease transactions are not material.

The Company incurred $0.4 million of ROU asset impairments during the year ended December 31, 2019 related to facility leases from the SiriusDecisions acquisition. These impairments are included in acquisition and integrations costs in the Consolidated Statements of Income (Loss).